282 related articles for article (PubMed ID: 34289083)
1. Pharmacological characterisation of mouse calcitonin and calcitonin receptor-like receptors reveals differences compared with human receptors.
Garelja ML; Bower RL; Brimble MA; Chand S; Harris PWR; Jamaluddin MA; Petersen J; Siow A; Walker CS; Hay DL
Br J Pharmacol; 2022 Feb; 179(3):416-434. PubMed ID: 34289083
[TBL] [Abstract][Full Text] [Related]
2. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
3. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
4. Beyond CGRP: The calcitonin peptide family as targets for migraine and pain.
Rees TA; Hendrikse ER; Hay DL; Walker CS
Br J Pharmacol; 2022 Feb; 179(3):381-399. PubMed ID: 34187083
[TBL] [Abstract][Full Text] [Related]
5. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.
Edvinsson L; Grell AS; Warfvinge K
J Mol Neurosci; 2020 Jun; 70(6):930-944. PubMed ID: 32086679
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
7. Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Hay DL; Garelja ML; Poyner DR; Walker CS
Br J Pharmacol; 2018 Jan; 175(1):3-17. PubMed ID: 29059473
[TBL] [Abstract][Full Text] [Related]
8. Biological and small molecule strategies in migraine therapy with relation to the calcitonin gene-related peptide family of peptides.
Edvinsson L; Edvinsson JCA; Haanes KA
Br J Pharmacol; 2022 Feb; 179(3):371-380. PubMed ID: 34411289
[TBL] [Abstract][Full Text] [Related]
9. CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
Walker CS; Hay DL
Br J Pharmacol; 2013 Dec; 170(7):1293-307. PubMed ID: 23425327
[TBL] [Abstract][Full Text] [Related]
10. Specificity of porcine calcitonin receptor and calcitonin receptor-like receptor in the presence of receptor-activity-modifying proteins.
Kikumoto K; Katafuchi T; Minamino N
Hypertens Res; 2003 Feb; 26 Suppl():S15-23. PubMed ID: 12630807
[TBL] [Abstract][Full Text] [Related]
11. Adrenomedullin and related peptides: receptors and accessory proteins.
Muff R; Born W; Fischer JA
Peptides; 2001 Nov; 22(11):1765-72. PubMed ID: 11754962
[TBL] [Abstract][Full Text] [Related]
12. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
[TBL] [Abstract][Full Text] [Related]
13. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
[TBL] [Abstract][Full Text] [Related]
14. RAMPs as allosteric modulators of the calcitonin and calcitonin-like class B G protein-coupled receptors.
Pioszak AA; Hay DL
Adv Pharmacol; 2020; 88():115-141. PubMed ID: 32416865
[TBL] [Abstract][Full Text] [Related]
15. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
[TBL] [Abstract][Full Text] [Related]
16. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
17. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
18. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.
Lee SM; Hay DL; Pioszak AA
J Biol Chem; 2016 Apr; 291(16):8686-700. PubMed ID: 26895962
[TBL] [Abstract][Full Text] [Related]
20. CGRP receptor antagonists for migraine. Are they also AMY
Garelja ML; Walker CS; Hay DL
Br J Pharmacol; 2022 Feb; 179(3):454-459. PubMed ID: 34076887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]